Guyana vs Kyrgyzstan: Cause of death, by non-communicable diseases, ages 0-4, male
Guyana
21.6%
in 2021
Kyrgyzstan
22.5%
in 2021
Guyana rank
124th
Kyrgyzstan rank
122nd
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Guyana
- Kyrgyzstan
How they compare
Kyrgyzstan currently reports 22.5% against 21.6% in Guyana, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Guyana ahead.
Guyana ranks 124th and Kyrgyzstan ranks 122nd of 185 countries.
Across the 3 decades both report, Guyana averaged higher in 2 and Kyrgyzstan in 1.
Head to head by decade
| Decade | Guyana | Kyrgyzstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.6% | 11.6% | 3.9% | Guyana |
| 2010s | 21.3% | 19.5% | 1.8% | Guyana |
| 2020s | 21.6% | 22.4% | 0.8% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Guyana or Kyrgyzstan?
- Kyrgyzstan, at 22.5% against 21.6% in Guyana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Guyana and Kyrgyzstan?
- 0.9%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Guyana and Kyrgyzstan?
- 6 years are reported by both, from 2000 to 2021.
- How do Guyana and Kyrgyzstan rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Guyana ranks 124th and Kyrgyzstan ranks 122nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.